T 2117/12 (Immunogenic composition/GLAXOSMITHKLINE) of 17.01.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T211712.20170117
- Date of decision
- 17 January 2017
- Case number
- T 2117/12
- Petition for review of
- -
- Application number
- 06754596.2
- IPC class
- A61K 39/102A61K 39/095A61K 39/116
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunogenic composition
- Applicant name
- GlaxoSmithKline Biologicals S.A.
- Opponent name
- Sanofi Pasteur, Inc.
Novartis Vaccines and Diagnostics, Inc. (opposition withdrawn) - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.